MASSACHUSETTS INSTITUTE OF TECHNOLOGY won EO14042 CONTROLLED PROTEIN CAPTURE VIA CONTINUOUS CRYSTALLIZATION AND PRECIPITATION FOR MONOCLONAL ANTIBODY MANUFACTURING - BAA PMQWP 324 from Food and Drug Administration

Food and Drug Administration · United States government award

GlobalGov surfaces government contract awards from around the world, including the markets your competitors overlook.

$5.0M
Award Value
June 12, 2025
Award Date
Awarded
Status

Award Overview

MASSACHUSETTS INSTITUTE OF TECHNOLOGY was awarded EO14042 CONTROLLED PROTEIN CAPTURE VIA CONTINUOUS CRYSTALLIZATION AND PRECIPITATION FOR MONOCLONAL ANTIBODY MANUFACTURING - BAA PMQWP 324 by Food and Drug Administration in United States, tracked by GlobalGov. The award is valued at $5.0M. It was awarded on June 12, 2025. Classification: NAICS 541714, PSC AN11. Full award details and the issuing agency are below.

See who is winning government contracts in this market — and the open opportunities coming next. Track awards, incumbents, and recompetes worldwide. Free for 14 days, no card.

Start Free

Award Details

AwardeeMASSACHUSETTS INSTITUTE OF TECHNOLOGY
Awardee countryUnited States
Awarding agencyFood and Drug Administration
CountryUnited States
Award value$5.0M
Award dateJune 12, 2025
NAICS541714
PSCAN11
Place of performanceUnited States
Last verifiedSeptember 1, 2026

Source: U.S. Government (USAspending.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.

Track every United States contract award and the opportunities behind them. Free for 14 days.

Get incumbent intelligence, recompete alerts, and deadline tracking for this market and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required